Wells Fargo
NARI

Wells Fargo’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Wells Fargo’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-105,742
Closed -$5.4M – 7351
2024
Q4 		$5.4M Buy
105,742
+2,678
+3% +$132K ﹤0.01% 2381
2024
Q3 		$4.25M Buy
103,064
+9,341
+10% +$449K ﹤0.01% 2470
2024
Q2 		$4.51M Sell
93,723
-8,766
-9% -$389K ﹤0.01% 2342
2024
Q1 		$4.92M Buy
102,489
+6,695
+7% +$358K ﹤0.01% 2263
2023
Q4 		$6.22M Buy
95,794
+1,033
+1% +$62.2K ﹤0.01% 2056
2023
Q3 		$6.2M Buy
94,761
+11,206
+13% +$705K ﹤0.01% 1952
2023
Q2 		$4.86M Sell
83,555
-8,693
-9% -$548K ﹤0.01% 2173
2023
Q1 		$5.7M Buy
92,248
+41,294
+81% +$2.48M ﹤0.01% 2018
2022
Q4 		$3.24M Sell
50,954
-12,210
-19% -$885K ﹤0.01% 2395
2022
Q3 		$4.59M Sell
63,164
-2,634
-4% -$196K ﹤0.01% 2060
2022
Q2 		$4.47M Sell
65,798
-232,217
-78% -$16.7M ﹤0.01% 2178
2022
Q1 		$27M Sell
298,015
-3,061
-1% -$251K 0.01% 1124
2021
Q4 		$27.5M Sell
301,076
-1,541,828
-84% -$132M 0.01% 1119
2021
Q3 		$149M Buy
1,842,904
+153,412
+9% +$12.9M 0.03% 488
2021
Q2 		$158M Buy
1,689,492
+291,145
+21% +$28.2M 0.03% 468
2021
Q1 		$150M Buy
1,398,347
+77,829
+6% +$8.08M 0.03% 488
2020
Q4 		$115M Buy
1,320,518
+818,787
+163% +$57.8M 0.03% 578
2020
Q3 		$34.6M Buy
501,731
+458,765
+1,068% +$29.5M 0.01% 1062
2020
Q2 		$2.08M Buy
+42,966
New +$2.05M ﹤0.01% 3235

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $307M AUM 20.33% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return

Wells Fargo's NARI Position: Q1 2025 in Review

Wells Fargo sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 105,742 shares — an estimated $5.4M sold.

Wells Fargo first reported a position in NARI in Q2 2020 and held it in 19 quarters. The position peaked at $158M in Q2 2021. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Wells Fargo reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Wells Fargo sold 105,742 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $5.4M.
  • Wells Fargo first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 19 quarters.
  • Wells Fargo's Inari Medical, Inc. Common Stock position peaked at $158M in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Wells Fargo's 13F filing for Q1 2025, filed 13 May 2025.